相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Cefiderocol for the Treatment of Infections Due to Metallo-B-lactamase-Producing Pathogens in the CREDIBLE-CR and APEKS-NP Phase 3 Randomized Studies
Jean-Francois Timsit et al.
CLINICAL INFECTIOUS DISEASES (2022)
Cefiderocol for the Treatment of Metallo-β-Lactamases Producing Gram-Negative Bacilli: Lights and Shadows From the Literature
Marco Falcone et al.
CLINICAL INFECTIOUS DISEASES (2022)
Cefiderocol- Compared to Colistin-Based Regimens for the Treatment of Severe Infections Caused by Carbapenem-Resistant Acinetobacter baumannii
Marco Falcone et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2022)
Impact of a Rapid Molecular Test for Klebsiella pneumoniae Carbapenemase and Ceftazidime-Avibactam Use on Outcomes After Bacteremia Caused by Carbapenem-Resistant Enterobacterales
Michael J. Satlin et al.
CLINICAL INFECTIOUS DISEASES (2022)
Efficacy of Ceftazidime-avibactam Plus Aztreonam in Patients With Bloodstream Infections Caused by Metallo-β-lactamase-Producing Enterobacterales
Marco Falcone et al.
CLINICAL INFECTIOUS DISEASES (2021)
Randomized Trial Evaluating Clinical Impact of RAPid IDentification and Susceptibility Testing for Gram-negative Bacteremia: RAPIDS-GN
Ritu Banerjee et al.
CLINICAL INFECTIOUS DISEASES (2021)
Assessment of Data Supporting the Efficacy of New Antibiotics for Treating Infections Caused by Multidrug-resistant Bacteria
Dafna Yahav et al.
CLINICAL INFECTIOUS DISEASES (2021)
Daptomycin Plus Fosfomycin Versus Daptomycin Alone for Methicillin-resistant Staphylococcus aureus Bacteremia and Endocarditis: A Randomized Clinical Trial
Miquel Pujol et al.
CLINICAL INFECTIOUS DISEASES (2021)
Cefiderocol as Rescue Therapy for Acinetobacter baumannii and Other Carbapenem-resistant Gram-negative Infections in Intensive Care Unit Patients
Marco Falcone et al.
CLINICAL INFECTIOUS DISEASES (2021)
Ceftobiprole Compared With Vancomycin Plus Aztreonam in the Treatment of Acute Bacterial Skin and Skin Structure Infections: Results of a Phase 3, Randomized, Double-blind Trial (TARGET)
J. Scott Overcash et al.
CLINICAL INFECTIOUS DISEASES (2021)
Is it time to move away from polymyxins?: evidence and alternatives
Rajeev Soman et al.
EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES (2021)
Efficacy and safety of cefiderocol or best available therapy for the treatment of serious infections caused by carbapenem-resistant Gram-negative bacteria (CREDIBLE-CR): a randomised, open-label, multicentre, pathogen-focused, descriptive, phase 3 trial
Matteo Bassetti et al.
LANCET INFECTIOUS DISEASES (2021)
Ceftazidime/avibactam in the era of carbapenemase-producing Klebsiella pneumoniae: experience from a national registry study
I Karaiskos et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2021)
Surviving sepsis campaign: international guidelines for management of sepsis and septic shock 2021
Laura Evans et al.
INTENSIVE CARE MEDICINE (2021)
Colistin Nephrotoxicity: Meta-Analysis of Randomized Controlled Trials
Khalid Eljaaly et al.
OPEN FORUM INFECTIOUS DISEASES (2021)
Ceftazidime-Avibactam Use for Klebsiella pneumoniae Carbapenemase-Producing K. pneumoniae Infections: A Retrospective Observational Multicenter Study
Mario Tumbarello et al.
CLINICAL INFECTIOUS DISEASES (2021)
How do I manage a patient with enterococcal bacteraemia?
Elena Rosselli Del Turco et al.
CLINICAL MICROBIOLOGY AND INFECTION (2021)
Can we trust strong recommendations based on low quality evidence?
Liang Yao et al.
BMJ-BRITISH MEDICAL JOURNAL (2021)
Epidemiology of Carbapenem Resistance Determinants Identified in Meropenem-Nonsusceptible Enterobacterales Collected as Part of a Global Surveillance Program, 2012 to 2017
Krystyna M. Kazmierczak et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2021)
A Phase 3, Randomized, Double-Blind Study Comparing Tedizolid Phosphate and Linezolid for Treatment of Ventilated Gram-Positive Hospital-Acquired or Ventilator-Associated Bacterial Pneumonia
Richard G. Wunderink et al.
CLINICAL INFECTIOUS DISEASES (2021)
Meropenem-Vaborbactam as Salvage Therapy for Ceftazidime-Avibactam-, Cefiderocol-Resistant ST-512 Klebsiella pneumoniae-Producing KPC-31, a D179Y Variant of KPC-3
Giusy Tiseo et al.
OPEN FORUM INFECTIOUS DISEASES (2021)
Evolutionary Trajectories toward Ceftazidime-Avibactam Resistance in Klebsiella pneumoniae Clinical Isolates
Alessandra Carattoli et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2021)
Resistance to ceftazidime/avibactam in infections and colonisations by KPC-producing Enterobacterales: a systematic review of observational clinical studies
Stefano Di Bella et al.
JOURNAL OF GLOBAL ANTIMICROBIAL RESISTANCE (2021)
Treatment of methicillin-resistant Staphylococcus aureus (MRSA): updated guidelines from the UK
Nicholas M. Brown et al.
JAC-ANTIMICROBIAL RESISTANCE (2021)
Infectious Diseases Society of America Guidance on the Treatment of Extended-Spectrum β-lactamase Producing Enterobacterales (ESBL-E), Carbapenem-Resistant Enterobacterales (CRE), and Pseudomonas aeruginosa with Difficult-to-Treat Resistance (DTR-P. aeruginosa)
Pranita D. Tamma et al.
CLINICAL INFECTIOUS DISEASES (2021)
Defining the Breakpoint Duration of Staphylococcus aureus Bacteremia Predictive of Poor Outcomes
Emi Minejima et al.
CLINICAL INFECTIOUS DISEASES (2020)
Ceftolozane/Tazobactam vs Polymyxin or Aminoglycoside-based Regimens for the Treatment of Drug-resistant Pseudomonas aeruginosa
Jason M. Pogue et al.
CLINICAL INFECTIOUS DISEASES (2020)
RESTORE-IMI 1: A Multicenter, Randomized, Double-blind Trial Comparing Efficacy and Safety of Imipenem/Relebactam vs Colistin Plus Imipenem in Patients With Imipenem-nonsusceptible Bacterial Infections
Johann Motsch et al.
CLINICAL INFECTIOUS DISEASES (2020)
Daily practice and prognostic factors for pneumonia caused by methicillin-resistant Staphylococcus aureus in Japan: A multicenter prospective observational cohort study
Taiga Miyazaki et al.
JOURNAL OF INFECTION AND CHEMOTHERAPY (2020)
A systematic review and meta-analysis of treatment outcomes following antibiotic therapy among patients with carbapenem-resistant Klebsiella pneumoniae infections
Akosua A. Agyeman et al.
INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS (2020)
Ceftazidime-Avibactam To Treat Life-Threatening Infections by Carbapenem-Resistant Pathogens in Critically Ill Mechanically Ventilated Patients
Vasiliki Tsolaki et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2020)
Meropenem-Vaborbactam versus Ceftazidime-Avibactam for Treatment of Carbapenem-Resistant Enterobacteriaceae Infections
Renee Ackley et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2020)
Does This Patient Need Blood Cultures? A Scoping Review of Indications for Blood Cultures in Adult Nonneutropenic Inpatients
Valeria Fabre et al.
CLINICAL INFECTIOUS DISEASES (2020)
Carbapenem-Resistant Enterobacterales, Carbapenem Resistant Organisms, Carbapenemase-Producing Enterobacterales, and Carbapenemase-Producing Organisms: Terminology Past its Sell-By Date in an Era of New Antibiotics and Regional Carbapenemase Epidemiology
David M. Livermore et al.
CLINICAL INFECTIOUS DISEASES (2020)
Follow-up blood cultures are associated with improved outcome of patients with gram -negative bloodstream infections: retrospective observational cohort study
M. Giannella et al.
CLINICAL MICROBIOLOGY AND INFECTION (2020)
Positive follow-up blood cultures identify high mortality risk among patients with Gram-negative bacteraemia
S. A. Maskarinec et al.
CLINICAL MICROBIOLOGY AND INFECTION (2020)
Is colistin-associated acute kidney injury clinically important in adults? A systematic review and meta-analysis
Hsiu-Ting Chien et al.
INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS (2020)
The Impact of Integrating Rapid PCR-Based Blood Culture Identification Panel to an Established Antimicrobial Stewardship Program in the United Arab of Emirates
Rama Nasef et al.
INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES (2020)
Effect of Vancomycin or Daptomycin With vs Without an Antistaphylococcal β-Lactam on Mortality, Bacteremia, Relapse, or Treatment Failure in Patients With MRSA Bacteremia A Randomized Clinical Trial
Steven Y. C. Tong et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2020)
Assessing impact of MALDI mass spectroscopy on reducing directed antibiotic coverage time for Gram-negative organisms
Calvin Ka-Fung Lo et al.
PLOS ONE (2020)
Clinical Features and Outcomes of Bloodstream Infections Caused by New Delhi Metallo-β-Lactamase-Producing Enterobacterales During a Regional Outbreak
Marco Falcone et al.
OPEN FORUM INFECTIOUS DISEASES (2020)
Infectious Diseases Consultation Is Associated With Decreased Mortality in Enterococcal Bloodstream Infections
Rachael A. Lee et al.
OPEN FORUM INFECTIOUS DISEASES (2020)
Therapeutic monitoring of vancomycin for serious -methicillin-resistant Staphylococcus aureus infections: A revised consensus guideline and review by the American Society of Health-System Pharmacists, the Infectious Diseases Society of America, the Pediatric Infectious Diseases Society, and the Society of Infectious Diseases Pharmacists
Michael J. Rybak et al.
AMERICAN JOURNAL OF HEALTH-SYSTEM PHARMACY (2020)
Clinical efficacy and safety of polymyxins based versus non-polymyxins based therapies in the infections caused by carbapenem-resistant Acinetobacter baumannii: a systematic review and meta-analysis
Cheng Lyu et al.
BMC INFECTIOUS DISEASES (2020)
How to design a study to evaluate therapeutic drug monitoring in infectious diseases?
A-G Martson et al.
CLINICAL MICROBIOLOGY AND INFECTION (2020)
Impact of rapid microbial identification on clinical outcomes in bloodstream infection: the RAPIDO randomized trial
A. MacGowan et al.
CLINICAL MICROBIOLOGY AND INFECTION (2020)
Antimicrobial therapeutic drug monitoring in critically ill adult patients: a Position Paper#
Mohd H. Abdul-Aziz et al.
INTENSIVE CARE MEDICINE (2020)
Pharmacokinetic/pharmacodynamic adequacy of polymyxin B against extensively drug-resistant Gram-negative bacteria in critically ill, general ward and cystic fibrosis patient populations
Jiao Xie et al.
INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS (2020)
Clinical significance of follow-up blood culture in patients with a single Staphylococcus aureus-positive blood culture
Taeeun Kim et al.
INFECTIOUS DISEASES (2020)
Impact of Rapid Antimicrobial Susceptibility Testing in Gram-Negative Rod Bacteremia: a Quasi-experimental Study
Catherine Anne Hogan et al.
JOURNAL OF CLINICAL MICROBIOLOGY (2020)
Risk Factors for Positive Follow-Up Blood Cultures in Gram-Negative Bacilli Bacteremia: Implications for Selecting Who Needs Follow-Up Blood Cultures
Hayato Mitaka et al.
OPEN FORUM INFECTIOUS DISEASES (2020)
Towards precision medicine: Therapeutic drug monitoring-guided dosing of vancomycin and β-lactam antibiotics to maximize effectiveness and minimize toxicity
Jaclyn A. Cusumano et al.
AMERICAN JOURNAL OF HEALTH-SYSTEM PHARMACY (2020)
Double-carbapenem therapy in the treatment of multidrug resistant Gram-negative bacterial infections: a systematic review and meta-analysis
Yuan-yuan Li et al.
BMC INFECTIOUS DISEASES (2020)
Adherence to standards of care and mortality in the management of Staphylococcus aureus bacteraemia in Peru: A prospective cohort study
Alvaro Schwalb et al.
INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES (2020)
Prevalence of Antibiotic-Resistant Pathogens in Culture-Proven Sepsis and Outcomes Associated With Inadequate and Broad-Spectrum Empiric Antibiotic Use
Chanu Rhee et al.
JAMA NETWORK OPEN (2020)
Defining persistent Staphylococcus aureus bacteraemia: secondary analysis of a prospective cohort study
Richard Kuehl et al.
LANCET INFECTIOUS DISEASES (2020)
Predictive scoring models for persistent gram-negative bacteremia that reduce the need for follow-up blood cultures: a retrospective observational cohort study
Jongtak Jung et al.
BMC INFECTIOUS DISEASES (2020)
Follow-up blood cultures in Gram-negative bacilli bacteremia: are they needed for critically ill patients?
Martina Spaziante et al.
MINERVA ANESTESIOLOGICA (2020)
Treatment options forK. pneumoniae,P. aeruginosaandA. baumanniico-resistant to carbapenems, aminoglycosides, polymyxins and tigecycline: an approach based on the mechanisms of resistance to carbapenems
Stamatis Karakonstantis et al.
INFECTION (2020)
The Changing Landscape of Uncomplicated Gram-Negative Bacteremia: A Narrative Review to Guide Inpatient Management
Jeannie D. Chan et al.
JOURNAL OF HOSPITAL MEDICINE (2020)
Predictors of Mortality in Patients with Carbapenem-Resistant Gram-Negative Bacilli or Vancomycin-Resistant Enterococci Bacteremia
Hye Jin Shi et al.
INFECTION AND DRUG RESISTANCE (2020)
An Appraisal of the Pharmacokinetic and Pharmacodynamic Properties of Meropenem-Vaborbactam
Eric Wenzler et al.
INFECTIOUS DISEASES AND THERAPY (2020)
Linking antimicrobial resistance surveillance to antibiotic policy in healthcare settings: the COMBACTE-Magnet EPI-Net COACH project
Maria Diletta Pezzani et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2020)
Are Follow-Up Blood Cultures Useful in the Antimicrobial Management of Gram Negative Bacteremia? A Reappraisal of Their Role Based on Current Knowledge
Francesco Cogliati Dezza et al.
ANTIBIOTICS-BASEL (2020)
Time to appropriate antibiotic therapy is a predictor of outcome in patients with bloodstream infection caused by KPC-producing Klebsiella pneumoniae
Marco Falcone et al.
CRITICAL CARE (2020)
Efficacy of Ceftazidime-Avibactam Salvage Therapy in Patients With Infections Caused by Klebsiella pneumoniae Carbapenemase-producing K-pneumoniae
Mario Tumbarello et al.
CLINICAL INFECTIOUS DISEASES (2019)
Current use of daptomycin and systematic therapeutic drug monitoring: Clinical experience in a tertiary care institution
Alicia Galar et al.
INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS (2019)
The Infectious Diseases Society of America's 10 x ′20 Initiative (10 New Systemic Antibacterial Agents US Food and Drug Administration Approved by 2020): Is 20 x ′20 a Possibility?
George H. Talbot et al.
CLINICAL INFECTIOUS DISEASES (2019)
Efficacy and Safety of Intravenous-to-oral Lefamulin, a Pleuromutilin Antibiotic, for the Treatment of Community-acquired Bacterial Pneumonia: The Phase III Lefamulin Evaluation Against Pneumonia (LEAP 1) Trial
Thomas M. File et al.
CLINICAL INFECTIOUS DISEASES (2019)
Follow-up blood cultures add little value in the management of bacteremic urinary tract infections
HyeJin Shi et al.
EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES (2019)
Methicillin-resistant Staphylococcus aureus: an overview of basic and clinical research
Nicholas A. Turner et al.
NATURE REVIEWS MICROBIOLOGY (2019)
Efficacy and Safety of Tedizolid Phosphate versus Linezolid in a Randomized Phase 3 Trial in Patients with Acute Bacterial Skin and Skin Structure Infection
Xiaoju Lv et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2019)
The implementation of rapid microbial identification via MALDI-ToF reduces mortality in gram-negative but not gram-positive bacteremia
Hila Zadka et al.
EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES (2019)
Efficacy of ceftazidime-avibactam in the treatment of infections due to Carbapenem-resistant Enterobacteriaceae
Basem M. Alraddadi et al.
BMC INFECTIOUS DISEASES (2019)
Epidemiology and Treatment of Multidrug-Resistant and Extensively Drug-Resistant Pseudomonas aeruginosa Infections
Juan P. Horcajada et al.
CLINICAL MICROBIOLOGY REVIEWS (2019)
Therapeutic drug monitoring-guided continuous infusion of piperacillin/tazobactam significantly improves pharmacokinetic target attainment in critically ill patients: a retrospective analysis of four years of clinical experience
Daniel C. Richter et al.
INFECTION (2019)
Efficacy of ceftazidime/avibactam in monotherapy or combination therapy against carbapenem-resistant Gram-negative bacteria: A meta-analysis
Lorenzo Onorato et al.
INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS (2019)
Development of quality indicators for the management of Staphylococcus aureus bacteraemia
Jaap ten Oever et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2019)
Proactive therapeutic drug monitoring (TDM) may be helpful in managing long-term treatment with linezolid safely: findings from a monocentric, prospective, open-label, interventional study
Pier Giorgio Cojutti et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2019)
The impact of a rapid molecular identification test on positive blood cultures from critically ill with bacteremia: A pre-post intervention study
Alexia Verroken et al.
PLOS ONE (2019)
Clinical Outcomes Of Colistin In Combination With Either 6-G Sulbactam Or Carbapenems For The Treatment Of Extensively Drug-Resistant Acinetobacter Baumannii Pneumonia With High MIC To Sulbactam, A Prospective Cohort Study
Chutchawan Ungthammakhun et al.
INFECTION AND DRUG RESISTANCE (2019)
Timing of follow-up blood cultures for community-onset bacteremia
Ching-Chi Lee et al.
SCIENTIFIC REPORTS (2019)
Attributable deaths and disability-adjusted life-years caused by infections with antibiotic-resistant bacteria in the EU and the European Economic Area in 2015: a population-level modelling analysis
Alessandro Cassini et al.
LANCET INFECTIOUS DISEASES (2019)
Colistin Plus Carbapenem versus Colistin Monotherapy in the Treatment of Carbapenem-Resistant Acinetobacter baumannii Pneumonia
HyeJin Shi et al.
INFECTION AND DRUG RESISTANCE (2019)
Optimization of the treatment with beta-lactam antibiotics in critically ill patientsguidelines from the French Society of Pharmacology and Therapeutics (Societe Francaise de Pharmacologie et TherapeutiqueSFPT) and the French Society of Anaesthesia and Intensive Care Medicine (Societe Francaise d'Anesthesie et ReanimationSFAR)
Romain Guilhaumou et al.
CRITICAL CARE (2019)
The effect of a rapid molecular blood test on the use of antibiotics for nosocomial sepsis: a randomized clinical trial
Cristhieni Rodrigues et al.
JOURNAL OF INTENSIVE CARE (2019)
Comparative efficacy and safety of treatment options for MDR and XDR Acinetobacter baumannii infections: a systematic review and network meta-analysis
Kirati Kengkla et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2018)
A Comparison of the Efficacy and Safety of Intravenous Followed by Oral Delafloxacin With Vancomycin Plus Aztreonam for the Treatment of Acute Bacterial Skin and Skin Structure Infections: A Phase 3, Multinational, Double-Blind, Randomized Study
William O'Riordan et al.
CLINICAL INFECTIOUS DISEASES (2018)
Prospective Trials Are Required to Alter Practice for Follow-up Blood Cultures for Gram-Negative Bacilli Bacteremia
Robert Benson Jones et al.
CLINICAL INFECTIOUS DISEASES (2018)
Intravenous colistin combination antimicrobial treatment vs. monotherapy: a systematic review and meta-analysis
Konstantinos Z. Vardakas et al.
INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS (2018)
Effect of combination therapy containing a high-dose carbapenem on mortality in patients with carbapenem-resistant Klebsiella pneumoniae bloodstream infection
Maddalena Giannella et al.
INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS (2018)
Evaluation of treatment outcomes of patients with MRSA bacteremia following antimicrobial stewardship programs with pharmacist intervention
Kengo Ohashi et al.
INTERNATIONAL JOURNAL OF CLINICAL PRACTICE (2018)
Effectiveness of ceftazidime/avibactam as salvage therapy for treatment of infections due to OXA-48 carbapenemase-producing Enterobacteriaceae
Adrian Sousa et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2018)
Colistin alone versus colistin plus meropenem for treatment of severe infections caused by carbapenem-resistant Gram-negative bacteria: an open-label, randomised controlled trial
Mical Paul et al.
LANCET INFECTIOUS DISEASES (2018)
Infectious Diseases Consultation Reduces 30-Day and 1-Year All-Cause Mortality for Multidrug-Resistant Organism Infections
Jason P. Burnham et al.
OPEN FORUM INFECTIOUS DISEASES (2018)
Phenotypic and Genotypic Characterization of Carbapenem-resistant Enterobacteriaceae: Data From a Longitudinal Large-scale CRE Study in China (2012-2016)
Qi Wang et al.
CLINICAL INFECTIOUS DISEASES (2018)
Active monotherapy and combination therapy for extensively drug-resistant Pseudomonas aeruginosa pneumonia
Thana Khawcharoenporn et al.
INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS (2018)
Therapeutic drug monitoring of beta-lactam antibiotics in the critically ill: direct measurement of unbound drug concentrations to achieve appropriate drug exposures
Gloria Wong et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2018)
Colistin versus Colistin Combined with Ampicillin-Sulbactam for Multiresistant Acinetobacter baumannii Ventilator-associated Pneumonia Treatment: An Open-label Prospective Study
Demosthenes Makris et al.
INDIAN JOURNAL OF CRITICAL CARE MEDICINE (2018)
Colistin Versus Ceftazidime-Avibactam in the Treatment of Infections Due to Carbapenem-Resistant Enterobacteriaceae
David van Duin et al.
CLINICAL INFECTIOUS DISEASES (2018)
Effect and Safety of Meropenem-Vaborbactam versus Best-Available Therapy in Patients with Carbapenem-Resistant Enterobacteriaceae Infections: The TANGO II Randomized Clinical Trial
Richard G. Wunderink et al.
INFECTIOUS DISEASES AND THERAPY (2018)
Vancomycin therapeutic drug monitoring and population pharmacokinetic models in special patient subpopulations
Joaquim F. Monteiro et al.
PHARMACOLOGY RESEARCH & PERSPECTIVES (2018)
The Effect of Molecular Rapid Diagnostic Testing on Clinical Outcomes in Bloodstream Infections: A Systematic Review and Meta-analysis
Tristan T. Timbrook et al.
CLINICAL INFECTIOUS DISEASES (2017)
Complete adherence to evidence-based quality-of-care indicators for Staphylococcus aureus bacteremia resulted in better prognosis
Miki Nagao et al.
INFECTION (2017)
Polymyxin monotherapy or in combination against carbapenem-resistant bacteria: systematic review and meta-analysis
Oren Zusman et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2017)
The global epidemiology of carbapenemase-producing Enterobacteriaceae
David van Duin et al.
VIRULENCE (2017)
MALDI-ToF short incubation identification from blood cultures is associated with reduced length of hospitalization and a decrease in bacteremia associated mortality
J. A. Delport et al.
EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES (2017)
Impact of β-lactam antibiotic therapeutic drug monitoring on dose adjustments in critically ill patients undergoing continuous renal replacement therapy
Caleb J. P. Economou et al.
INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS (2017)
Clinical efficacy of ceftazidime/avibactam versus other active agents for the treatment of bacteremia due to carbapenemase-producing Enterobacteriaceae in hematologic patients
Juan J. Caston et al.
INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES (2017)
Efficacy and safety of delafloxacin compared with vancomycin plus aztreonam for acute bacterial skin and skin structure infections: a Phase 3, double-blind, randomized study
J. Pullman et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2017)
Integration of DPC and clinical microbiological data in Japan reveals importance of confirming a negative follow-up blood culture in patients with MRSA bacteremia
Naoki Miyamoto et al.
JOURNAL OF INFECTION AND CHEMOTHERAPY (2017)
A Placebo-Controlled Trial of Antibiotics for Smaller Skin Abscesses
Robert S. Daum et al.
NEW ENGLAND JOURNAL OF MEDICINE (2017)
Emergence of Ceftazidime-Avibactam Resistance and Restoration of Carbapenem Susceptibility in Klebsiella pneumoniae Carbapenemase-Producing K pneumoniae: A Case Report and Review of Literature
Ryan K. Shields et al.
OPEN FORUM INFECTIOUS DISEASES (2017)
Follow-up Blood Cultures in Gram-Negative Bacteremia: Are They Needed?
Christina N. Canzoneri et al.
CLINICAL INFECTIOUS DISEASES (2017)
Mobile health application to assist doctors in antibiotic prescription - an approach for antibiotic stewardship
Felipe Francisco Tuon et al.
BRAZILIAN JOURNAL OF INFECTIOUS DISEASES (2017)
A 10-Year Experience of Therapeutic Drug Monitoring (TDM) of Linezolid in a Hospital-wide Population of Patients Receiving Conventional Dosing: Is there Enough Evidence for Suggesting TDM in the Majority of Patients?
Federico Pea et al.
BASIC & CLINICAL PHARMACOLOGY & TOXICOLOGY (2017)
Clinical Outcome and Antimicrobial Therapeutic Drug Monitoring for the Treatment of Infections in Acute Burn Patients
Anna Silva Machado et al.
CLINICAL THERAPEUTICS (2017)
Ceftazidime-Avibactam Is Superior to Other Treatment Regimens against Carbapenem-Resistant Klebsiella pneumoniae Bacteremia
Ryan K. Shields et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2017)
Multicenter Study of Outcomes with Ceftazidime-Avibactam in Patients with Carbapenem-Resistant Enterobacteriaceae Infections
Madeline King et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2017)
Can Ceftazidime-Avibactam and Aztreonam Overcome β-Lactam Resistance Conferred by Metallo-β-Lactamases in Enterobacteriaceae?
Steven Marshall et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2017)
Impact of MALDI-TOF-MS-based identification directly from positive blood cultures on patient management: a controlled clinical trial
M. Osthoff et al.
CLINICAL MICROBIOLOGY AND INFECTION (2017)
Combination of Vancomycin and β-Lactam Therapy for Methicillin-Resistant Staphylococcus aureus Bacteremia: A Pilot Multicenter Randomized Controlled Trial
Joshua S. Davis et al.
CLINICAL INFECTIOUS DISEASES (2016)
Effectiveness of Practices To Increase Timeliness of Providing Targeted Therapy for Inpatients with Bloodstream Infections: a Laboratory Medicine Best Practices Systematic Review and Meta-analysis
Stephanie S. Buehler et al.
CLINICAL MICROBIOLOGY REVIEWS (2016)
Performance of processes of care and outcomes in patients with Staphylococcus aureus bacteremia
Rossana Rosa et al.
JOURNAL OF HOSPITAL MEDICINE (2016)
Sending repeat cultures: is there a role in the management of bacteremic episodes? (SCRIBE study)
J. Brad Wiggers et al.
BMC INFECTIOUS DISEASES (2016)
A Randomized Trial of Clindamycin Versus Trimethoprim-sulfamethoxazole for Uncomplicated Wound Infection
David A. Talan et al.
CLINICAL INFECTIOUS DISEASES (2016)
Impact of rapid identification of Acinetobacter Baumannii via matrix-assisted laser desorption ionization time-of-flight mass spectrometry combined with antimicrobial stewardship in patients with pneumonia and/or bacteremia
Eric Wenzler et al.
DIAGNOSTIC MICROBIOLOGY AND INFECTIOUS DISEASE (2016)
A Phase III, randomized, controlled, non-inferiority trial of ceftaroline fosamil 600 mg every 8 h versus vancomycin plus aztreonam in patients with complicated skin and soft tissue infection with systemic inflammatory response or underlying comorbidities
Matthew Dryden et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2016)
Spotlight on ceftazidime/avibactam: a new option for MDR Gram-negative infections
Marco Falcone et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2016)
Guideline panels should seldom make good practice statements: guidance from the GRADE Working Group
Gordon H. Guyatt et al.
JOURNAL OF CLINICAL EPIDEMIOLOGY (2016)
Trimethoprim-Sulfamethoxazole versus Placebo for Uncomplicated Skin Abscess
David A. Talan et al.
NEW ENGLAND JOURNAL OF MEDICINE (2016)
An open-label, pragmatic, randomized controlled clinical trial to evaluate the comparative effectiveness of daptomycin versus vancomycin for the treatment of complicated skin and skin structure infection
Teresa L. Kauf et al.
BMC INFECTIOUS DISEASES (2015)
Randomized Trial of Rapid Multiplex Polymerase Chain Reaction-Based Blood Culture Identification and Susceptibility Testing
Ritu Banerjee et al.
CLINICAL INFECTIOUS DISEASES (2015)
Use of old antibiotics now and in the future from a pharmacokinetic/pharmacodynamic perspective
A. E. Muller et al.
CLINICAL MICROBIOLOGY AND INFECTION (2015)
Rapid Diagnosis of Infection in the Critically Ill, a Multicenter Study of Molecular Detection in Bloodstream Infections, Pneumonia, and Sterile Site Infections
Jean-Louis Vincent et al.
CRITICAL CARE MEDICINE (2015)
Executive summary of the diagnosis and treatment of bacteremia and endocarditis due to Staphylococcus aureus. A clinical guideline from the Spanish Society of Clinical Microbiology and Infectious Diseases (SEIMC)
Francesc Gudiol et al.
ENFERMEDADES INFECCIOSAS Y MICROBIOLOGIA CLINICA (2015)
β-Lactam pharmacokinetics during extracorporeal membrane oxygenation therapy: A case-control study
Katia Donadello et al.
INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS (2015)
Can therapeutic drug monitoring optimize exposure to piperacillin in febrile neutropenic patients with haematological malignancies? A randomized controlled trial
Fekade Bruck Sime et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2015)
Guideline panels should not GRADE good practice statements COMMENT
Gordon H. Guyatt et al.
JOURNAL OF CLINICAL EPIDEMIOLOGY (2015)
Prospective intervention study with a microarray-based, multiplexed, automated molecular diagnosis instrument (Verigene system) for the rapid diagnosis of bloodstream infections, and its impact on the clinical outcomes
Hiromichi Suzuki et al.
JOURNAL OF INFECTION AND CHEMOTHERAPY (2015)
Clindamycin versus Trimethoprim-Sulfamethoxazole for Uncomplicated Skin Infections
Loren G. Miller et al.
NEW ENGLAND JOURNAL OF MEDICINE (2015)
Trimethoprim-sulfamethoxazole versus vancomycin for severe infections caused by meticillin resistant Staphylococcus aureus: randomised controlled trial
Mical Paul et al.
BMJ-BRITISH MEDICAL JOURNAL (2015)
Trimethoprim-sulfamethoxazole versus vancomycin for severe infections caused by meticillin resistant Staphylococcus aureus: randomised controlled trial
Mical Paul et al.
BMJ-BRITISH MEDICAL JOURNAL (2015)
Optimization of time to initial vancomycin target trough improves clinical outcomes
Anthony P. Cardile et al.
SPRINGERPLUS (2015)
Single-Dose Oritavancin Versus 7-10 Days of Vancomycin in the Treatment of Gram-Positive Acute Bacterial Skin and Skin Structure Infections: The SOLO II Noninferiority Study
G. Ralph Corey et al.
CLINICAL INFECTIOUS DISEASES (2015)
Impact of same-day antibiotic susceptibility testing on time to appropriate antibiotic treatment of patients with bacteraemia: a randomised controlled trial
J. Beuving et al.
EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES (2015)
Preliminary Study of Colistin versus Colistin plus Fosfomycin for Treatment of Carbapenem-Resistant Acinetobacter baumannii Infections
Rujipas Sirijatuphat et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2014)
A Phase 3 Randomized Double-Blind Comparison of Ceftobiprole Medocaril Versus Ceftazidime Plus Linezolid for the Treatment of Hospital-Acquired Pneumonia
Samir S. Awad et al.
CLINICAL INFECTIOUS DISEASES (2014)
DALI: Defining Antibiotic Levels in Intensive Care Unit Patients: Are Current β-Lactam Antibiotic Doses Sufficient for Critically Ill Patients?
Jason A. Roberts et al.
CLINICAL INFECTIOUS DISEASES (2014)
Therapeutic drug monitoring-based dose optimisation of piperacillin and meropenem: a randomised controlled trial
Jan J. De Waele et al.
INTENSIVE CARE MEDICINE (2014)
Integrating rapid diagnostics and antimicrobial stewardship improves outcomes in patients with antibiotic-resistant Gram-negative bacteremia
Katherine K. Perez et al.
JOURNAL OF INFECTION (2014)
Tedizolid for 6 days versus linezolid for 10 days for acute bacterial skin and skin-structure infections (ESTABLISH-2): a randomised, double-blind, phase 3, non-inferiority trial
Gregory J. Moran et al.
LANCET INFECTIOUS DISEASES (2014)
Single-Dose Oritavancin in the Treatment of Acute Bacterial Skin Infections
G. Ralph Corey et al.
NEW ENGLAND JOURNAL OF MEDICINE (2014)
Once-Weekly Dalbavancin versus Daily Conventional Therapy for Skin Infection
Helen W. Boucher et al.
NEW ENGLAND JOURNAL OF MEDICINE (2014)
A Multidisciplinary Intervention to Reduce Infections of ESBL-and AmpC-Producing, Gram-Negative Bacteria at a University Hospital
Jenny Dahl Knudsen et al.
PLOS ONE (2014)
A Randomized, Double-blind, Comparative Study to Assess the Safety and Efficacy of Topical Retapamulin Ointment 1% Versus Oral Linezolid in the Treatment of Secondarily Infected Traumatic Lesions and Impetigo Due to Methicillin-Resistant Staphylococcus aureus
Tonny Tanus et al.
ADVANCES IN SKIN & WOUND CARE (2014)
Implementation of a Computerized Decision Support System to Improve the Appropriateness of Antibiotic Therapy Using Local Microbiologic Data
Manuel Rodriguez-Maresca et al.
BIOMED RESEARCH INTERNATIONAL (2014)
Phase II Clinical Study of BC-3781, a Pleuromutilin Antibiotic, in Treatment of Patients with Acute Bacterial Skin and Skin Structure Infections
W. T. Prince et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2013)
Can a routine follow-up blood culture be justified in Klebsiella pneumoniae bacteremia? a retrospective case-control study
Chang Kyung Kang et al.
BMC INFECTIOUS DISEASES (2013)
A Quality-of-Care Bundle for Treatment of Staphylococcus aureus Bacteremia: Ready for Prime Time?
Catherine Liu
CLINICAL INFECTIOUS DISEASES (2013)
Colistin and Rifampicin Compared With Colistin Alone for the Treatment of Serious Infections Due to Extensively Drug-Resistant Acinetobacter baumannii: A Multicenter, Randomized Clinical Trial
Emanuele Durante-Mangoni et al.
CLINICAL INFECTIOUS DISEASES (2013)
Colistin vs. the combination of colistin and rifampicin for the treatment of carbapenem-resistant Acinetobacter baumannii ventilator-associated pneumonia
H. Aydemir et al.
EPIDEMIOLOGY AND INFECTION (2013)
Tedizolid Phosphate vs Linezolid for Treatment of Acute Bacterial Skin and Skin Structure Infections The ESTABLISH-1 Randomized Trial
Philippe Prokocimer et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2013)
Benefits of Therapeutic Drug Monitoring of Vancomycin: A Systematic Review and Meta-Analysis
Zhi-Kang Ye et al.
PLOS ONE (2013)
Linezolid in Methicillin-Resistant Staphylococcus aureus Nosocomial Pneumonia: A Randomized, Controlled Study
Richard G. Wunderink et al.
CLINICAL INFECTIOUS DISEASES (2012)
Time to positivity of follow-up blood cultures in patients with persistent Staphylococcus aureus bacteremia
S. H. Choi et al.
EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES (2012)
Carbapenem-resistant Pseudomonas aeruginosa pneumonia with intermediate minimum inhibitory concentrations to doripenem: combination therapy with high-dose, 4-h infusion of doripenem plus fosfomycin versus intravenous colistin plus fosfomycin
Anucha Apisarnthanarak et al.
INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS (2012)
The rise of the Enterococcus: beyond vancomycin resistance
Cesar A. Arias et al.
NATURE REVIEWS MICROBIOLOGY (2012)
Telavancin versus Vancomycin for HospitalAcquired Pneumonia due to Gram-positive Pathogens
Ethan Rubinstein et al.
CLINICAL INFECTIOUS DISEASES (2011)
Clinical Practice Guidelines by the Infectious Diseases Society of America for the Treatment of Methicillin-Resistant Staphylococcus Aureus Infections in Adults and Children
Catherine Liu et al.
CLINICAL INFECTIOUS DISEASES (2011)
Mortality in enterococcal bloodstream infections increases with inappropriate antimicrobial therapy
M. Suppli et al.
CLINICAL MICROBIOLOGY AND INFECTION (2011)
Efficacy and safety of linezolid versus vancomycin for the treatment of complicated skin and soft-tissue infections proven to be caused by methicillin-resistant Staphylococcus aureus
Kamal M. F. Itani et al.
AMERICAN JOURNAL OF SURGERY (2010)
Randomized Controlled Trial of Trimethoprim-Sulfamethoxazole for Uncomplicated Skin Abscesses in Patients at Risk for Community-Associated Methicillin-Resistant Staphylococcus aureus Infection
Gillian R. Schmitz et al.
ANNALS OF EMERGENCY MEDICINE (2010)
Therapeutic Drug Monitoring of Linezolid: a Retrospective Monocentric Analysis
Federico Pea et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2010)
Daptomycin Exposure and the Probability of Elevations in the Creatine Phosphokinase Level: Data from a Randomized Trial of Patients with Bacteremia and Endocarditis
Sujata M. Bhavnani et al.
CLINICAL INFECTIOUS DISEASES (2010)
Complicated Skin and Skin-Structure Infections and Catheter-Related Bloodstream Infections: Noninferiority of Linezolid in a Phase 3 Study
Mark H. Wilcox et al.
CLINICAL INFECTIOUS DISEASES (2009)
A randomized, double-blind trial comparing ceftobiprole medocaril with vancomycin plus ceftazidime for the treatment of patients with complicated skin and skin-structure infections
Gary J. Noel et al.
CLINICAL INFECTIOUS DISEASES (2008)
Telavancin versus vancomycin for the treatment of complicated skin and skin-structure infections caused by gram-positive organisms
Martin E. Stryjewski et al.
CLINICAL INFECTIOUS DISEASES (2008)
GRADE:: an emerging consensus on rating quality of evidence and strength of recommendations
Gordon H. Guyatt et al.
BRITISH MEDICAL JOURNAL (2008)
Results of a double-blind, randomized trial of ceftobiprole treatment of complicated skin and skin structure infections caused by gram-positive bacteria
Gary J. Noel et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2008)
Daptomycin versus standard therapy for bacteremia and endocarditis caused by Staphylococcus aureus
Vance G. Fowler et al.
NEW ENGLAND JOURNAL OF MEDICINE (2006)
Randomized, double-blind comparison of once-weekly dalbavancin versus twice-daily linezolid therapy for the treatment of complicated skin and skin structure infections
LE Jauregui et al.
CLINICAL INFECTIOUS DISEASES (2005)
Safety and efficacy of tigecycline in treatment of skin and skin structure infections: Results of a double-blind phase 3 comparison study with vancomycin-aztreonam
J Breedt et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2005)
Efficacy and safety of tigecycline monotherapy compared with vancomycin plus aztreonam in patients with complicated skin and skin structure infections: Results from a phase 3, randomized, double-blind trial
S Sacchidanand et al.
INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES (2005)
Linezolid versus vancomycin in treatment of complicated skin and soft tissue infections
J Weigelt et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2005)
Linezolid compared with teicoplanin for the treatment of suspected or proven Gram-positive infections
M Wilcox et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2004)
Teicoplanin therapeutic drug monitoring in critically ill patients: a retrospective study emphasizing the importance of a loading dose
F Pea et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2003)
Continuation of a randomized, double-blind, multicenter study of linezolid versus vancomycin in the treatment of patients with nosocomial pneumonia
RG Wunderink et al.
CLINICAL THERAPEUTICS (2003)
Linezolid versus vancomycin for the treatment of methicillin-resistant Staphylococcus aureus infections
DL Stevens et al.
CLINICAL INFECTIOUS DISEASES (2002)
Emerging carbapenemases in Gram-negative aerobes
P Nordmann et al.
CLINICAL MICROBIOLOGY AND INFECTION (2002)
Linezolid (PNU-100766) versus vancomycin in the treatment of hospitalized patients with nosocomial pneumonia: A randomized, double-blind, multicenter study
E Rubinstein et al.
CLINICAL INFECTIOUS DISEASES (2001)
分享论文
